HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
29 hedge funds and large institutions have $12M invested in Hepion Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
17% more call options, than puts
Call options by funds: $657K | Put options by funds: $562K
Holders
29
Holding in Top 10
–
Calls
$657K
Puts
$562K
Top Buyers
| 1 | +$3.79M | |
| 2 | +$2.48M | |
| 3 | +$721K | |
| 4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$512K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$408K |
Top Sellers
| 1 | -$178K | |
| 2 | -$103K | |
| 3 | -$48K | |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
-$36K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$19.6K |